These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 9607177)
21. Adducin and hypertension. Staessen JA; Bianchi G Pharmacogenomics; 2005 Oct; 6(7):665-9. PubMed ID: 16207143 [TBL] [Abstract][Full Text] [Related]
22. Genetics of primary hypertension: the clinical impact of adducin polymorphisms. Citterio L; Lanzani C; Manunta P; Bianchi G Biochim Biophys Acta; 2010 Dec; 1802(12):1285-98. PubMed ID: 20382219 [TBL] [Abstract][Full Text] [Related]
23. Alpha-adducin gene polymorphism is associated with essential hypertension in Chinese: a case-control and family-based study. Ju Z; Zhang H; Sun K; Song Y; Lu H; Hui R; Huang X J Hypertens; 2003 Oct; 21(10):1861-8. PubMed ID: 14508192 [TBL] [Abstract][Full Text] [Related]
24. Rostafuroxin: an ouabain-inhibitor counteracting specific forms of hypertension. Ferrari P Biochim Biophys Acta; 2010 Dec; 1802(12):1254-8. PubMed ID: 20083196 [TBL] [Abstract][Full Text] [Related]
25. Targeting Ouabain- and Adducin-dependent mechanisms of hypertension and cardiovascular remodeling as a novel pharmacological approach. Ferrari P; Ferrandi M; Valentini G; Manunta P; Bianchi G Med Hypotheses; 2007; 68(6):1307-14. PubMed ID: 17097240 [TBL] [Abstract][Full Text] [Related]
26. Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: a double-blinded, randomized, placebo-controlled crossover trial. Matthesen SK; Larsen T; Vase H; Lauridsen TG; Jensen JM; Pedersen EB Clin Exp Hypertens; 2013; 35(5):313-24. PubMed ID: 22966789 [TBL] [Abstract][Full Text] [Related]
27. alpha-adducin and angiotensin I-converting enzyme polymorphisms in essential hypertension. Clark CJ; Davies E; Anderson NH; Farmer R; Friel EC; Fraser R; Connell JM Hypertension; 2000 Dec; 36(6):990-4. PubMed ID: 11116113 [TBL] [Abstract][Full Text] [Related]
28. PST 2238: a new antihypertensive compound that modulates renal Na-K pump function without diuretic activity in Milan hypertensive rats. Ferrandi M; Barassi P; Minotti E; Duzzi L; Molinari I; Bianchi G; Ferrari P J Cardiovasc Pharmacol; 2002 Dec; 40(6):881-9. PubMed ID: 12451321 [TBL] [Abstract][Full Text] [Related]
29. Association between hypertension and variation in the alpha- and beta-adducin genes in a white population. Wang JG; Staessen JA; Barlassina C; Fagard R; Kuznetsova T; Struijker-Boudier HA; Zagato L; Citterio L; Messaggio E; Bianchi G Kidney Int; 2002 Dec; 62(6):2152-9. PubMed ID: 12427140 [TBL] [Abstract][Full Text] [Related]
30. PST 2238: a new antihypertensive compound that modulates the Na-K pump 'in vivo' and 'in vitro'. Ferrari P; Ferrandi M; Torielli L; Tripodi G; Bianchi G Hypertens Res; 2000 Sep; 23 Suppl():S15-9. PubMed ID: 11016814 [TBL] [Abstract][Full Text] [Related]
31. Genetic aspects of ion transport systems in hypertension. Bianchi G; Ferrari P; Cusi D; Tripodi G; Barber B J Hypertens Suppl; 1990 Dec; 8(7):S213-8. PubMed ID: 1710265 [TBL] [Abstract][Full Text] [Related]
32. NKCC2 is activated in Milan hypertensive rats contributing to the maintenance of salt-sensitive hypertension. Carmosino M; Rizzo F; Ferrari P; Torielli L; Ferrandi M; Bianchi G; Svelto M; Valenti G Pflugers Arch; 2011 Aug; 462(2):281-91. PubMed ID: 21553016 [TBL] [Abstract][Full Text] [Related]
33. Rostafuroxin: an ouabain antagonist that corrects renal and vascular Na+-K+- ATPase alterations in ouabain and adducin-dependent hypertension. Ferrari P; Ferrandi M; Valentini G; Bianchi G Am J Physiol Regul Integr Comp Physiol; 2006 Mar; 290(3):R529-35. PubMed ID: 16467500 [TBL] [Abstract][Full Text] [Related]
34. Lack of association between Gly460Trp polymorphism of alpha-adducin gene and salt sensitivity of blood pressure in Polish hypertensives. Ciechanowicz A; Widecka K; Drozd R; Adler G; Cyryłowski L; Czekalski S Kidney Blood Press Res; 2001; 24(3):201-6. PubMed ID: 11528213 [TBL] [Abstract][Full Text] [Related]
35. Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension. Psaty BM; Smith NL; Heckbert SR; Vos HL; Lemaitre RN; Reiner AP; Siscovick DS; Bis J; Lumley T; Longstreth WT; Rosendaal FR JAMA; 2002 Apr; 287(13):1680-9. PubMed ID: 11926892 [TBL] [Abstract][Full Text] [Related]
36. Association between adducin-1 G460W variant and blood pressure in Swedes is dependent on interaction with body mass index and gender. Fava C; Montagnana M; Almgren P; Rosberg L; Guidi GC; Berglund G; Melander O Am J Hypertens; 2007 Sep; 20(9):981-9. PubMed ID: 17765140 [TBL] [Abstract][Full Text] [Related]
37. Hypertension-linked mutation of α-adducin increases CFTR surface expression and activity in HEK and cultured rat distal convoluted tubule cells. Mondini A; Sassone F; Civello DA; Garavaglia ML; Bazzini C; Rodighiero S; Vezzoli V; Conti F; Torielli L; Capasso G; Paulmichl M; Meyer G PLoS One; 2012; 7(12):e52014. PubMed ID: 23284854 [TBL] [Abstract][Full Text] [Related]
38. Epistatic interaction between alpha- and gamma-adducin influences peripheral and central pulse pressures in white Europeans. Cwynar M; Staessen JA; Tichá M; Nawrot T; Citterio L; Kuznetsova T; Wojciechowska W; Stolarz K; Filipovský J; Kawecka-Jaszcz K; Grodzicki T; Struijker-Boudier HA; Thijs L; Van Bortel LM; Bianchi G; J Hypertens; 2005 May; 23(5):961-9. PubMed ID: 15834281 [TBL] [Abstract][Full Text] [Related]